Cormorant Asset Management LP, Shareholder at Bright Minds Biosciences, holds 950.00K shares in Bright Minds Biosciences (Ticker: TSE:DRUG). Most recently, Cormorant Asset Management LP Sold 109,331 shares of Bright Minds Biosciences on Apr 30, 2026 for an estimated value of C$9.79M.
What was Cormorant Asset Management LP’s latest transaction?
Cormorant Asset Management LP latest transaction was an Informative Sell of C$9.79M.
What was Cormorant Asset Management LP's most profitable transaction?
Cormorant Asset Management LP’s most profitable transaction was an Informative Sell of TSE:DRUG stock on April 30, 2026. The return on the trade was 6.10%.
What is Cormorant Asset Management LP's role in Bright Minds Biosciences?
Cormorant Asset Management LP's role in Bright Minds Biosciences is Shareholder.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.